Middle East: [NPR] describes a blockade lift and a 60-day runway toward a fuller agreement, but [Al-Monitor] and [DW] emphasize the fragility of the process as meetings slip and calendars reset—exactly the kind of delay that can keep commercial shipping cautious even after “reopening” claims.
Europe: [France24] says a US pharma pricing probe could escalate into tariffs, and the implications would land unevenly—on patients, insurers, and exporters—depending on how “innovation” and “fair pricing” get defined.
Africa: Ebola is breaking through the noise. [The Guardian] reports emergency CDC funding, while [Thenewhumanitarian] stresses that community trust and historical grievance shape outcomes as much as clinical protocols.
Indo-Pacific: supply chains remain jittery: [Nikkei Asia] reports Japanese companies warning that disruption may be a “new normal” even after a US–Iran deal headline.
Americas: [ProPublica] reports more than 770,000 children have lost SNAP benefits after policy changes—an under-discussed stressor that can reshape health and school outcomes long after the news cycle moves on.